Sackler Family and Purdue Pharma Agree to $7.4 Billion Settlement Over U.S. Opioid Crisis

The agreement, pending court approval, includes Sackler payments over 15 years and aims to fund addiction treatment and prevention programs nationwide.

• The Sackler family will pay up to $6.5 billion over 15 years, while Purdue Pharma will contribute $900 million as part of the settlement.
• The deal resolves lawsuits from 15 U.S. states and other parties holding Purdue and the Sacklers accountable for the opioid epidemic.
• The settlement ends Sackler family control of Purdue Pharma, with the company now overseen by entities representing suing states and groups.
• Funds from the settlement will support addiction treatment, prevention, and recovery initiatives across affected communities in the U.S.
• The opioid crisis, fueled in part by Purdue's OxyContin, has caused over 700,000 deaths in the U.S. since 1999, with the Sacklers accused of misleading marketing practices.

3 Articles

DER SPIEGEL Die Tageszeitung Stern